As at 4:19 AM on 19/5/2013
The Share Price is: 57.50 GBX
Home > News
As you’d expect from a company in emerging technologies and world class IP, our companies generate considerable news. Full details of all RNS and portfolio company related announcements are detailed below:
Simcyp enhances flagship simulator in line with pharmaceutical industry priorities.
06 May 2009
Interim Results for the period ended 31st Jan 2009
24 Apr 2009
Demasq gains FDA approval and appoints new chairman
01 Apr 2009
250k Co-investment secures drug therapy development in wales
£350,000 Investment into Adjuvantix
25 Feb 2009
Annual Report and Accounts
27 Jan 2009
Trade Sale of Axordia Limited to Intercytex Group plc
22 Dec 2008
Preliminary results for the year ended 31 July 2008
08 Oct 2008
Magnomatics raises £0.5m to accelerate technology development
29 Sep 2008
Phase Focus completes first 'lenless' optical microscope prototype and raises £250k in additional funding
26 Sep 2008